- GPS-enabled location device developer MetAlert provides geographical tracking technology that is discrete and functional through shoe inserts that provide data connectivity to cognitive patient caregivers
- MetAlert announced in January that it is expanding the reach of its SmartSole flagship product through an agreement with Sweden’s government that was established by distribution partner Posifon AB
- Government agencies across Europe and in the United States have recognized the importance of being able to monitor the whereabouts of patients with cognitive concerns
- MetAlert’s development team has improved the SmartSole with a battery capable of lasting up to five days, and the company plans to roll out its -Plus model later this quarter with Bluetooth and Wi-Fi capability for enhanced data monitoring of falls and other medical concerns
Wearable tracking and health monitoring device developer MetAlert (OTC: MLRT) provides relief to the world’s elderly and medical patients prone to confusion through the company’s flagship product — an insertable shoe insole equipped with tech that transmits vital information about the wearer to caregivers.
Initially designed to track the location of individuals prone to wander, MetAlert’s innovative GPS-enabled SmartSole units have, through continued development, gained the capacity to provide location-specific information in indoor, home environments through a Wi-Fi connection in its…
NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
